SCHEMBL24310110

SCHEMBL24310110

CCc1c(Oc2ccc(N3CCNCC3)cc2)nc(N[S+]([O-])c2cnn(C)c2)nc1-c1cc(C)ccc1C

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RET P07949 3/20 0.33
▸ ACVR1 Q04771 3/20 0.33
▸ CCNB2 O95067 1/20 0.32
▸ CCNE2 O96020 1/20 0.32
▸ CDK1 P06493 1/20 0.32
▸ CDK4 P11802 1/20 0.32
▸ CCNB1 P14635 1/20 0.32
▸ CCNA2 P20248 1/20 0.32
▸ CCND1 P24385 1/20 0.32
▸ CCNE1 P24864 1/20 0.32
▸ CDK2 P24941 1/20 0.32
▸ CCND2 P30279 1/20 0.32
▸ CCND3 P30281 1/20 0.32
▸ CCNA1 P78396 1/20 0.32
▸ CCNB3 Q8WWL7 1/20 0.32
▸ LCK P06239 1/20 0.31
▸ JAK3 P52333 1/20 0.31
▸ BTK Q06187 1/20 0.31
▸ TNK2 Q07912 1/20 0.31
▸ RIPK2 O43353 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310071 0.91 LCK (0.35) RETACVR1CCNB2CCNE2CDK1
SCHEMBL24310038 0.88 TNK2 (0.35) RETACVR1CCNB2CCNE2CDK1
SCHEMBL29566496 0.84 NOD2 (0.36) ACVR1CCNB2CCNE2CDK1CDK4
SCHEMBL24310104 0.84 NOD2 (0.36) ACVR1CCNB2CCNE2CDK1CDK4
SCHEMBL29567089 0.75 HTR6 (0.37) ACVR1LCKJAK3BTKTNK2
SCHEMBL24310067 0.75 HTR6 (0.37) ACVR1LCKJAK3BTKTNK2
SCHEMBL24310026 0.74 ACVR1 (0.32) RETACVR1CCNB2CCNE2CDK1
SCHEMBL24310021 0.73 NOD2 (0.36) ACVR1LCKJAK3BTKTNK2
SCHEMBL29566401 0.73 NOD2 (0.36) ACVR1LCKJAK3BTKTNK2
SCHEMBL26811442 0.73 NOD2 (0.40) ACVR1RIPK2NOD2ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback